Kin‐Chun Luk

Inactivation of Mirk/Dyrk1b Kinase Targets Quiescent Pancreatic Cancer Cells

Daina Z. Ewton, Jing Hu, Maria Vilenchik et al. · Molecular Cancer Therapeutics · 2011 · 67 citations · Full text

Medicine, Oncology, Pharmacology +17

Discovery of potent and selective spiroindolinone MDM2 inhibitor, RO8994, for cancer therapy

Zhuming Zhang, Qingjie Ding, Jinjun Liu et al. · Bioorganic & Medicinal Chemistry · 2014 · 57 citations

Medicine, Medicinal Chemistry, Pharmacology +7

Pyrido[2,3-d]pyrimidines: Discovery and preliminary SAR of a novel series of DYRK1B and DYRK1A inhibitors

K. Anderson, Yi Chen, Zhi Chen et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 54 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

A new series of potent oxindole inhibitors of CDK2

Kin‐Chun Luk, Mary Ellen Simcox, Andy Schutt et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 51 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Synthesis of Potent Oxindole CDK2 Inhibitors

Apos Dermatakis, Kin‐Chun Luk, Wanda DePinto · Bioorganic & Medicinal Chemistry · 2003 · 48 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10